Author: Ken Dropiewski

HeartStitch® Inc. has received CE Mark for Its Suture Based Trans-Apical Access and Closure

ZWICKAU, Germany, April 12, 2018 /PRNewswire/ — HeartStitch® Trans-Apical Access and Closure device provides safe and effective percutaneous trans-apical access for structural heart procedures and reliable closure. The proven suture-based technique emulates surgical closure without the need for open heart surgery or limited thoracotomy access (open surgical access to the heart between the ribs) when […]

Ventricular Assist Devices Market Expected to Reach $1,773 Million, Globally, by 2023 – Allied Market Research

PORTLAND, Oregon and PUNE, India, April 12, 2018 /PRNewswire/ — According to a new report published by Allied Market Research, titled, ” Ventricular Assist Devices Market by Product, Application, and Design: Global Opportunity Analysis and Industry Forecast, 2017-2023,” the global ventricular assist devices market was valued at $809 million in 2016, and is estimated to reach $1,773 million by […]

Murj Expands Offering to Manage In-Office Cardiac Device Monitoring

SANTA CRUZ, Calif.–(BUSINESS WIRE)– Murj, Inc., a healthcare technology company focused on transforming implantable cardiac device management, today announced the availability of OnSite™— the industry’s first cloud-based workflow solution for in-office cardiac device management. OnSite is an extension of Murj’s proven workflow for remote transmission management. With today’s announcement, Murj […]

Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease

ABBOTT PARK, Ill., April 11, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced the initiation of a clinical trial evaluating long-term outcomes of patients who undergo stent implantation guided by high-resolution light-based imaging technology—called optical coherence tomography (OCT)—compared to a common X-ray-guided technique called angiography. The trial (ILUMIEN IV) is the first large-scale randomized global […]

Merit Medical Systems to Announce First Quarter Results on April 25, 2018

SOUTH JORDAN, Utah, April 11, 2018 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the […]

SecurAcath Selected for Fast-Track NHS Use Through New Innovation and Technology Payment Program

PLYMOUTH, Minn.–(BUSINESS WIRE)–Interrad Medical, a privately held medical device company, announces the SecurAcath Subcutaneous Catheter Securement Device has been selected for the Innovation and Technology Payment (ITP) Program by the National Health Service (NHS) England. The ITP Program is designed to remove significant barriers to the spread and adoption of […]

NHS England to Provide Innovation and Technology Payment (ITP) to Drive Adoption of HeartFlow Analysis in the United Kingdom

REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that NHS England has chosen the HeartFlow® FFRct Analysis as part of the Innovation and Technology Payment (ITP) program. The HeartFlow Analysis was chosen as a new technology to be funded by ITP through a competitive process of nearly 300 applicants. It is the only ITP […]

JenaValve Technology Continues CE Mark Study Treating Severe Aortic Stenosis with Next-Generation System; Patient Enrollment and Successful Implantations with the Everdur™ Pericardial Aortic Valve and Coronatix™ Delivery Catheter

IRVINE, Calif.–(BUSINESS WIRE)–JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced successful patient enrollment in the CE Mark study of the next generation JenaValve Pericardial TAVR System utilizing the Coronatix™ Transfemoral Delivery Catheter for […]

HeartSciences Announces Publication of Clinical Trial Results in Journal of the American College of Cardiology (JACC)

SOUTHLAKE, Texas – ( BUSINESS WIRE ) – HeartSciences , a medical device company that is at the forefront of innovation in the field of electrocardiography thanks to the application of artificial intelligence and signal processing based on continuous waveforms (continuous wavelet transform, CWT), today announced the results of a clinical study conducted serially […]

Supporting Cells in the Heart Contribute to Cardiac Disease

WASHINGTON, April 9, 2018 /PRNewswire/ — An article published in Experimental Biology and Medicine (Volume 243, Issue 7, April, 2018) reports that supporting cells in the heart, known as fibroblasts, are selectively activated by factors present in heart disease. The study, led by Dr. Megan McCain, Assistant Professor in the Department of Biomedical Engineering and Department […]